# PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.

> **NCT00736502** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 280 (actual)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00736502
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2011-07
- **Final completion:** —
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2014-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736502, "PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00736502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*